Mylan Laboratories Inc. won a preliminary ruling in a patent dispute, clearing the way for approval of its generic version of Bristol-Myers Squibb Co.’s anti-anxiety drug BuSpar. U.S. District Judge ...
The settlement "isn't the end" of Bristol-Myers' legal woes, as "not all plaintiffs are settling" and "not all of the issues have been resolved" for those who have agreed to settle, the Wall Street ...
Buspirone price has fallen so low that many manufacturers claim they cannot make a profit on it. HealthDay News — A shortage of the anti-anxiety drug buspirone in the United States has patients and ...
A shortage of the anti-anxiety drug buspirone in the United States has patients and doctors concerned. HealthDay News — A shortage of the anti-anxiety drug buspirone in the United States has patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results